뼈 및 미네랄 진단 검사 시장 규모, 점유율 및 성장 분석 : 검사 유형별, 플랫폼별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Bone And Mineral Diagnostic Testing Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 3.75 Billion in 2025 to USD 6.22 Billion by 2033, growing at a CAGR of 6.52% during the forecast period (2026-2033).

The Global Bone and Mineral Diagnostic Testing market is significantly driven by the increasing prevalence of osteoporosis-related conditions, necessitating effective assessment tools. This sector encompasses technologies such as dual-energy X-ray absorptiometry (DEXA), quantitative computed tomography, and serum biomarkers that evaluate bone density and metabolic activity. Enhanced early intervention capabilities reduce fracture risks, morbidity, and overall healthcare costs. The integration of AI algorithms into testing processes further optimizes patient stratification, allowing for more precise risk assessments. Additionally, the evolution of reimbursement models promoting outcome-based care is creating a favorable environment for diagnostic testing. As insurers recognize the value of preventive screenings, testing volumes rise, fostering earlier detection and management of bone health, ultimately resulting in reduced fracture incidence and healthcare expenditures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone And Mineral Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone And Mineral Diagnostic Testing Market Segments Analysis

Global bone and mineral diagnostic testing market is segmented by test type, platform, application, end-user and region. Based on test type, the market is segmented into Bone Turnover Markers (CTX, P1NP), Calcium & Phosphate Testing, Vitamin D Testing and Parathyroid Hormone (PTH). Based on platform, the market is segmented into Immunoassay Analyzers and POC Testing. Based on application, the market is segmented into Osteoporosis Management, Chronic Kidney Disease-Mineral and Hyperparathyroidism. Based on end-user, the market is segmented into Hospitals, Diagnostic Labs and Endocrinology Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bone And Mineral Diagnostic Testing Market

One of the key market drivers for the global bone and mineral diagnostic testing market is the increasing prevalence of bone disorders, such as osteoporosis and osteomalacia, largely due to aging populations and lifestyle changes. As awareness of these conditions rises, there is a heightened demand for accurate diagnostic tests that can assess bone health and mineral density effectively. Additionally, advancements in technology and the development of innovative diagnostic tools, including non-invasive testing methods and point-of-care solutions, are further propelling market growth by ensuring quicker results and improved patient outcomes, thereby attracting both healthcare providers and patients to these diagnostic solutions.

Restraints in the Global Bone And Mineral Diagnostic Testing Market

One key market restraint for the global bone and mineral diagnostic testing market is the high cost associated with advanced diagnostic technologies and procedures. Many healthcare facilities, particularly in developing regions, may lack the financial resources to invest in state-of-the-art diagnostic equipment or to adopt expensive testing methods. Additionally, the complexities involved in interpreting test results can require highly trained personnel, further adding to operational costs. This financial barrier can limit access to necessary diagnostic tests, hindering market growth and restricting early diagnosis and treatment options for bone and mineral conditions in various populations.

Market Trends of the Global Bone And Mineral Diagnostic Testing Market

The Global Bone and Mineral Diagnostic Testing market is witnessing a significant trend driven by the expansion of precision imaging technologies. High-resolution peripheral quantitative computed tomography and advanced ultrasound are transforming the assessment of osteoporosis and metabolic bone diseases by providing site-specific, comprehensive bone quality evaluations that surpass conventional densitometry methods. This evolution not only enhances clinical decision-making through richer data for healthcare providers but also offers patients non-invasive, radiation-light options. Consequently, there is a growing demand for advanced diagnostic devices and an increase in collaborations between manufacturers and radiology networks, ultimately broadening the market's global reach.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bone and Mineral Diagnostic Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Bone Turnover Markers (CTX, P1NP)
• Calcium & Phosphate Testing
• Vitamin D Testing
• Parathyroid Hormone (PTH)

Global Bone and Mineral Diagnostic Testing Market Size by Platform & CAGR (2026-2033)

• Market Overview
• Immunoassay Analyzers
• POC Testing

Global Bone and Mineral Diagnostic Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Osteoporosis Management
• Chronic Kidney Disease-Mineral
• Hyperparathyroidism

Global Bone and Mineral Diagnostic Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Labs
• Endocrinology Clinics

Global Bone and Mineral Diagnostic Testing Market Size & CAGR (2026-2033)

• North America (Test Type, Platform, Application, End-User)
  • US
  • Canada
• Europe (Test Type, Platform, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Platform, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Platform, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Platform, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Wako Pure Chemical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoClinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meso Scale Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDS (Immunodiagnostic Systems)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diametra Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIAsource ImmunoAssays
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALPCO Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eagle Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LIAISON (DiaSorin)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations